S. Wan

发表

Phase I study of abiraterone acetate (AA) in patients (pts) with estrogen receptor- (ER) or androgen receptor (AR) -positive advanced breast carcinoma resistant to standard endocrine therapies.

M. Dowsett, A. Tutt, C. Swanton, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.